Spero Therapeutics Inc (NAS:SPRO)
$ 1.45 0 (0%) Market Cap: 78.28 Mil Enterprise Value: 1.25 Mil PE Ratio: 3.30 PB Ratio: 0.81 GF Score: 40/100

Spero Therapeutics Inc Conference Call Transcript

May 03, 2022 / 12:30PM GMT
Release Date Price: $1.85 (-63.65%)
Operator

Good morning, and welcome to the Spero Therapeutics Conference Call. (Operator Instructions) Please be advised that this call is being recorded and a replay will be available. You can find information on the replay and further information related to today's announcements on the Spero Therapeutics website at www.sperotherapeutics.com.

At this time, I would like to turn the call over to Ted Jenkins, Vice President, Investor Relations at Spero Therapeutics. Mr. Jenkins, please go ahead.

Ted Jenkins
Spero Therapeutics, Inc. - VP & Head of IR

Thank you, operator, and thank you all for participating in today's conference call. Earlier this morning, Spero Therapeutics issued a news release announcing the new strategic direction it intends to take following feedback from our recent late cycle meeting with the FDA. This feedback suggests that the new drug application data package for Spero's Phase III ADAPT-PO study in complicated urinary tract infection may be insufficient to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot